SL Science Holding Ltd（SLBT）资讯与事件

$1.150

-0.140 (-12.21%)收盘时

SLBT 资讯

SL Science Holding Reports Positive Data for Glioblastoma Treatment

SL Science Holding Files New Drug Master File with FDA

SL Science Files New Drug Master File with FDA

Biotech Stocks Surge with Significant Gains

SL Science Showcases γδ T Cell Therapy for Glioblastoma

SL Science Submits Orphan Drug Designation for Brain Cancer Treatment

SL Science Holding Submits Orphan Drug Designation for GBM Therapy

Biotech Companies See Significant Stock Gains

SL Science Reports 2025 Financial Results and Strategic Shift

Biotech Companies Achieve Significant Milestones

本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。